Genmab
Andrew Carlsen has a strong background in financial analysis and capital markets. Andrew has held positions such as Equity Research Analyst, Global Portfolio Manager, and Vice President of Investor Relations at various companies including Genmab, ABG Sundal Collier, and Novo Nordisk A/S. Andrew has also worked as a teaching assistant at Copenhagen University and has a Master of Science degree in Economics from the University of Copenhagen.
This person is not in any teams
Genmab
40 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.